๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Acute Leukemia in Remission

Clinical Study Protocol of Maintenance Therapy With Venetoclax in Elderly Patients With AML in First Complete Remission NCT05909293NA1 site๐Ÿ“ Nanjing The First Affiliated Hospital with Nanjing Medical Universiโ€ฆ ยท Tests: Venclexta 100 MG Oral Tablet CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia NCT07328503Phase 21 site๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: CD22 CAR-transduced T cells, Cyclophosphamide, Fludarabine A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia NCT07400029Phase 29 sites๐Ÿ“ Duarte๐Ÿ“ Stanford๐Ÿ“ Basking Ridge Memorial Sloan Kettering Cancer Center ยท Tests: Obecabtagene Autoleucel Ziftomenib Maintenance Post Allo-HCT NCT06440135Phase 12 sites๐Ÿ“ Boston๐Ÿ“ Columbus Massachusetts General Hospital ยท Tests: Ziftomenib Ruxolitinib-Decitabine Intensified Conditioning Regimen for AML: A Randomized Trial NCT07101588Phase 41 site๐Ÿ“ Beijing Chinese PLA General Hospital ยท Tests: Ruxolitinib, Decitabine Study Comparing the Efficacy of 2 RIC Regimens (Clofarabine vs Fludarabine) in Adults With AML Eligible to Allo-SCT NCT05917405Phase 223 sites๐Ÿ“ Nantes๐Ÿ“ Amiens๐Ÿ“ Angers Nantes University Hospital ยท Tests: Fludarabine, Busulfan, ATG, Clofarabine Comparing Post-Transplant Cyclophosphamide As GVHD Prophylaxis to Standard of Care for Acute Leukemia Patients NCT04314219Phase 31 site๐Ÿ“ Riyadh King Faisal Specialist Hospital & Research Center ยท Tests: Cyclophosphamide 50mg, Methotrexate Venetoclax Basket Trial for High Risk Hematologic Malignancies NCT05292664Phase 15 sites๐Ÿ“ San Francisco๐Ÿ“ Aurora๐Ÿ“ Atlanta Andrew E. Place, MD ยท Tests: Venetoclax, Azacitidine, Cytarabine, Methotrexate, Hydrocortisone MB-CART19.1 in Relapsed/Refractory Acute Lymphoblastic Leukemia NCT07371403NA1 site๐Ÿ“ Amman King Hussein Cancer Center ยท Tests: MB-CART19.1 MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies NCT05735717Phase 21 site๐Ÿ“ Minneapolis Masonic Cancer Center, University of Minnesota ยท Tests: Fludarabine, Busulfan, Melphalan, Rituximab, Levetiracetam Determining the Mechanisms of Loss of CAR T Cell Persistence NCT05809284n/a3 sites๐Ÿ“ London๐Ÿ“ London๐Ÿ“ Manchester University College, London Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission NCT06824168Phase 264 sites๐Ÿ“ Birmingham๐Ÿ“ Los Angeles๐Ÿ“ Baltimore Daiichi Sankyo ยท Tests: Quizartinib High Dose, Quizartinib Low Dose UCD19 CAR T Therapy in Adults With B-ALL and MRD Positivity in CR1 NCT05535855Phase 11 site๐Ÿ“ Aurora University of Colorado, Denver ยท Tests: CD19 Directed CAR T Cell A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph... NCT05621291NA8 sites๐Ÿ“ Los Angeles๐Ÿ“ Washington D.C.๐Ÿ“ Atlanta National Cancer Institute (NCI) ยท Tests: NGS testing Relation Between Venetoclax Plasma Concentration and Remission in Adults with Acute Myeloid Leukemia (PREDICLAX) NCT06045819n/a1 site๐Ÿ“ Caen University Hospital, Caen ยท Tests: Blood sampling for venetoclax drug dosage (venous puncture) Personalized NK Cell Therapy in CBT NCT02727803Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Allogeneic Natural Killer Cell Line NK-92, Anti-Thymocyte Globulin, Busulfan, Clofarabine, Cyclophosphamide Virtual Buddy Movement Therapy for Psychomotor and Social Development in Pediatric Oncology Patients in Remission NCT07522905NA1 site๐Ÿ“ Bratislava Comenius University ยท Tests: Virtual BUDDY-Movement Therapy MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing NCT05794880NA1 site๐Ÿ“ Milwaukee Medical College of Wisconsin ยท Tests: Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi) Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning NCT03852407Phase 210 sites๐Ÿ“ Antwerp๐Ÿ“ Bruges๐Ÿ“ Brussels University of Liege ยท Tests: Thymoglobulin, Melphalan, Fludarabine, Cyclophosphamid Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation NCT04935684Phase 220 sites๐Ÿ“ Amiens๐Ÿ“ Angers๐Ÿ“ Besanรงon University Hospital, Clermont-Ferrand ยท Tests: Fecal Microbiota Transplantation UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia NCT06245746Phase 11 site๐Ÿ“ Wuhan Union Hospital, Tongji Medical College, Huazhong Universityโ€ฆ ยท Tests: umbilical cord derived mesenchymal stem cells exosomes (UCMSC-Exo) The Maintenance Treatment of "ITIVA" in AML Patients NCT06256627NA1 site๐Ÿ“ Zhengzhou Henan Cancer Hospital ยท Tests: recombinant human interference'- ฮฑ- 1b, interleukin-2, thalidomide, Venentoclax and Azacitidine CD19/CD22 CAR-T Cells in Adults With R/R ALL or NHL NCT06445803Phase 12 sites๐Ÿ“ Nanchang๐Ÿ“ Shanghai Rong Tao ยท Tests: KQ-2002 CAR-T cells ๏ผˆCD19/CD22 CAR T-Cells๏ผ‰ Correlation of Venetoclax Plasma Concentrations With Toxicity of Hypometilating Agents and Venetoclax Combination for Acute Myeloid Leukemia Patients in Remission. NCT07254312n/a1 site๐Ÿ“ Pavia Fondazione IRCCS Policlinico San Matteo di Pavia Phase IB/II of CPX-351 for Relapse Prevention in AML NCT04990102Phase 1, Phase 23 sites๐Ÿ“ Washington D.C.๐Ÿ“ Hackensack๐Ÿ“ Philadelphia Georgetown University ยท Tests: CPX-351 XP-005 Personalized Vaccine Alone or in Combination With Toripalimab for the Prevention of Relapse After Remission in Acute Myeloid Leukemia NCT06980155EARLY Phase 11 site๐Ÿ“ Shanghai Shanghai Jiao Tong University School of Medicine ยท Tests: Personalized neoantigen tumor vaccine, PD-1 inhibitor Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT) NCT06462365Phase 15 sites๐Ÿ“ Duarte๐Ÿ“ Boston๐Ÿ“ Minneapolis Tr1X, Inc. ยท Tests: TRX103 AZA + Venetoclax as Maintenance Therapy in Younger Adults With AML in First Remission NCT05404906Phase 2, Phase 32 sites๐Ÿ“ Suzhou๐Ÿ“ Suzhou The First Affiliated Hospital of Soochow University ยท Tests: Azacitidine, Venetoclax, Supportive care Exploratory Study of CD22/CD19 Dual-Target CAR-T Cell Therapy as Consolidation Treatment After First Remission in High-Risk B-Cell Acute Lymphoblastic Leukemia NCT07575971Phase 1, Phase 21 site๐Ÿ“ Beijing Liping Dou ยท Tests: CD22/CD19 Dual-Target CAR-T Cells Clinical Study Protocol of IAV-induced Remission Followed by Consolidation Therapy With MDCyta+Ven in ND-AML NCT06232694NA1 site๐Ÿ“ Nanjing The First Affiliated Hospital with Nanjing Medical Universiโ€ฆ ยท Tests: Venetoclax : 100mg on day 1, 200mg on day 2, 400mg on days 3 to 8; oral administration;, Venetoclax (Venetoclax): 400mgโ€ฆ
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy